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Abstract
Purpose—To explore the correlation between optical coherence tomography (OCT) and
stereoscopic fundus photographs (FP) for the assessment of retinal thickening (RT) in diabetic
macular edema (DME) within a clinical trial.
Methods—OCT, FP, and best corrected visual acuity (VA) measurements were obtained in both
eyes of 263 participants in a trial comparing two photocoagulation techniques for DME. Correlation
coefficients (r) were calculated comparing RT measured by OCT, RT estimated from FP, and VA.
Principal variables were central subfield retinal thickness (CSRT) obtained from the OCT fast
macular map and DME severity assessed by a reading center using a seven-step photographic scale
combining the area of thickened retina within 1 disc diameter of the foveal center and thickening at
the center.
Results—Medians (quartiles) for retinal thickness within the center subfield by OCT at baseline
increased from 236 (214, 264) μm in the lowest level of the photographic scale to 517 (455, 598)
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μm in the highest level (r = 0.67). However, CSRT interquartile ranges were broad and overlapping
between FP scale levels, and there were many outliers. Correlations between either modality and VA
were weaker (r = 0.57 for CSRT, and r = 0.47 for the FP scale). OCT appeared to be more reproducible
and more sensitive to change in RT between baseline and 1 year than was FP.
Conclusions—There was a moderate correlation between OCT and FP assessments of RT in
patients with DME and slightly less correlation of either measure with VA. OCT and FP provide
complementary information but neither is a reliable surrogate for VA.
The location and severity of retinal thickening and hard exudates (lipid deposits) are defining
features of diabetic macular edema (DME) and correlate with concurrent visual acuity (VA)
and future VA loss.1–3 Clinically, these abnormalities have traditionally been assessed by
ophthalmoscopy and slit lamp biomicroscopy with contact or noncontact lenses. Stereoscopic
fundus photographs (FP), can provide similar information and have been the standard method
for documentation of diabetic retinopathy severity and DME in clinical trials.4
Optical coherence tomography (OCT) provides quantitative estimates of retinal thickness at
multiple points within the macular region, from which a retinal thickness map can be
constructed. The OCT instruments manufactured by Carl Zeiss Meditec (Dublin, CA), which
were used in our trial, provide estimates of mean retinal thickness within each of nine
subdivisions of the macular area and display them on a grid similar to that used in photographic
grading (Fig. 1) except that the largest OCT grid (using 6-mm scans) is somewhat smaller than
the photographic grid.4–6 Previous studies have found good agreement between clinical
examination and OCT on the presence or absence of definite retinal thickening at or near the
center of the macula (agreement 80%− 85%, κ = 0.60−0.70), but considerable disagreement
in eyes with more subtle thickening.5,7,8 Strom et al.9 reported good agreement (89%, κ =
0.69) on location of retinal thickening within the macular grid between FP and OCT in eyes
with mild DME that in most cases was located outside of the central subfield of the grid.9 To
our knowledge, no other studies have compared OCT and FP estimates of retinal thickening
in DME.
The extent of agreement between OCT and FP may be helpful in designing future clinical
studies and for developing practice guidelines. We therefore assessed the correlation between
retinal thickness measured by OCT and estimated from FP with a modification of the ETDRS
DME scale (see Appendix online at http://www.iovs.org/cgi/content/full/49/5/1745/ DC1) in
a randomized multicenter clinical trial comparing two photocoagulation strategies for DME.
In addition, the correlation of these measures with VA was evaluated.
Methods
The design, methods, and results of the trial have been published and are summarized briefly
herein.10 Best corrected electronic-ETDRS VA measurements, OCT, and FP were performed
on both eyes at baseline and at follow-up visits scheduled 3.5, 8, and 12 months thereafter.
Photocoagulation was performed at baseline and repeated during follow-up, according to study
guidelines if DME persisted or recurred. The trial adhered to the tenets of the Declaration of
Helsinki.
Participants were at least 18 years old and had type 1 or 2 diabetes mellitus. One or both eyes
met the following criteria to be a study eye in the trial: (1) best corrected VA score ≥19 letters
(∼20/400 or better), (2) definite retinal thickening (RT) due to previously untreated DME (and
not primarily due to vitreoretinal interface abnormalities as determined by the investigator)
within 500 μm of the macular center on clinical examination, and (3) mean OCT retinal
thickness of ≥250 μm in the central subfield or ≥300 μm in at least one of the four inner
subfields.
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A total of 263 participants were enrolled in the trial. In 60 of these individuals, both eyes were
eligible, and thus there were 323 study eyes and 203 non–study eyes. Of the non–study eyes,
58 had had prior treatment for DME and 6 had a baseline VA score of <19 letters. The remaining
139 non–study eyes, many of which had DME that was less severe than that required for
eligibility, or no DME at all, were included as candidates for analysis in this report, to broaden
the severity range of DME studied and to increase the dataset available for analysis. Of the 462
eyes that were candidates for analysis, 27 (6%) were excluded because of missing or ungradable
images (OCT 10 eyes, FP 15 eyes, both 2 eyes) leaving a total of 435 eyes (309 study eyes and
126 non–study eyes) of 257 participants. These 435 eyes were eligible for all baseline analyses
comparing OCT measurements and FP gradings. Additional analyses of relationships between
these morphologic measures and VA excluded 24 eyes with ocular abnormalities other than
DME identified by the reading center or by the investigator as likely to be sufficient to cause
decreased VA.
Only study eyes (all of which had been treated with photocoagulation at baseline) with gradable
baseline and 12-month visit photographs and OCTs were eligible for analyses examining
change between baseline and 12 months (n = 256 study eyes; 38 eyes were excluded because
of missing 12-month visits, and 15 eyes were excluded because of missing or ungradable 12-
month images [3 eyes missing/7 eyes ungradable by FP; 2 eyes missing/0 ungradable by OCT;
and 2 eyes missing/1 ungradable by both image types]).
The mean age of the 257 participants included in these analyses was 59 years; 40% were
women. The cohort was 65% white, 18% African American, 9% Hispanic, and 8% other races.
Type 2 diabetes was present in 93% of the participants. The mean duration of diabetes was 14
years and mean HbA1c was 8.1% (range, 4.6%−15.0%). Mean baseline E-ETDRS VA score
for the 435 eyes included in the baseline analyses was 76 letters (∼20/32). Visual acuity was
20/20 or better in 31%, 20/25 to 20/40 in 49%, 20/50 to 20/100 in 17%, and worse than 20/100
in 3% of eyes. The median (quartiles) OCT central subfield thickness of the 435 eyes was 273
(233, 364) μm. Fundus photograph gradings classified 37% of eyes in level 1 on the ETDRS
DME severity scale (center of macula not involved or threatened by RT), 22% in levels 2 or 3
(center threatened or mildly involved), and 41% in levels 4 or 5 (center moderately or severely
involved; see Appendix online). Retinopathy severity was graded as nonproliferative in 90%
of eyes (32% mild to moderate, 46% moderately severe, and 11% severe) and as proliferative
in 8% (retinopathy severity could not be assessed in 2% of the images). Eighty-eight percent
of eyes were phakic, and 3% had previous scatter photocoagulation.
Procedures
OCT—After pupillary dilation radial 6 mm scans were obtained from each eye by a certified
operator. The OCT 3 fast macular scan pattern was used for all measurements in 240
participants, the OCT 2 for some or all measurements in the remaining 17. Additional high-
resolution (512 A scan density) cross-hair scans (6−12 and 9−3 o'clock through the center of
the macula) were obtained for assessment of presence/absence of cystoid spaces, serous retinal
detachment, and vitreoretinal surface abnormalities. The six radial scans were assessed by the
reading center for quality, which was categorized as “good” if three criteria were met: (1) the
scans were centered on the macular center, (2) the SD of the mean of the six center point values
was not greater than 10%, and (3) there were no deviations of the anterior or posterior retinal
borders drawn by the software in any subfield that were estimated to produce an error of greater
than 10% in the thickness measurement calculated by the software for that subfield. If only the
first two criteria were met, quality was considered “fair,” and any subfield failing the third
criterion was designated ungradable, as was retinal volume for the eye. If the SD of the center
point was greater than 10% of its value, or if obvious errors were observed in centration of the
scans, the center point was measured manually, as long as other scan quality problems (e.g.,
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poor signal strength) did not preclude this possibility, and the overall quality of the OCT was
considered “borderline.” The manually measured center point thickness was used to impute
the value for the central subfield using a regression equation, since the correlation of the two
measures is 0.98.10,11 and only these two values were used in analysis. If a manual
measurement of the center point was not possible, the OCT was considered ungradable for
quantitative measures. Of the 435 eyes analyzed at baseline, OCT quality was good in 65%,
fair in 20%, borderline in 15%, and ungradable in <1%. Scans of both eyes were graded
concurrently by a single grader who was free to consult with a senior grader or reading-center
ophthalmologist regarding difficult cases. Reproducibility of retinal thickness in the central
subfield was analyzed in a previous DRCR.net report (different data set using the same
methods) in which the half widths of the 95% confidence intervals for absolute and relative
change between two measures were 38 μm and 11%, respectively.11
The standard output from the OCT radial line pattern provides retinal thickness (inclusive of
subretinal fluid, when present) in micrometers at the center point, mean thickness in each of
the nine subfields, and retinal volume within the grid as a whole. Additional measures used in
this report are mean measured retinal thickness in the inner zone (the average of the means of
the central and four inner subfields, weighted by subfield area), maximum calculated retinal
thickening in the inner zone (maximum thickening among the five subfields), and in the grid
as a whole (maximum thickening among all nine subfields). Calculated retinal thickening was
defined as measured retinal thickness minus normal thickness, using unpublished data provided
by Carl Zeiss Meditec from a 2005 OCT 3 study of 260 eyes of nondiabetic individuals with
normal macula in which the following mean ± SD thicknesses were determined: central
subfield, 202 ± 22 μm; inner superior, 269 ± 16 μm; inner nasal, 267 ± 17 μm; inner inferior,
271 ± 16 μm; inner temporal, 267 ± 17 μm; outer superior, 232 ± 15 μm; outer nasal, 235 ± 23
μm; outer inferior, 231 ± 15 μm; and outer temporal 237 ± 24 μm. We have emphasized
maximum calculated retinal thickening in the inner zone and measured retinal thickness in the
central subfield in this report, the former because it is most congruent with the eligibility criteria
for DME severity in the trial and corresponds most closely with the ETDRS DME severity
scale, and the latter because it is commonly used clinically and was the principal OCT variable
used in this trial.10
Fundus Photographs—ETDRS 7-standard-field FP were obtained using color film by
certified photographers and sent to the reading center for grading.4,12 Grading methods for
DME were the same as those used in the ETDRS, except that areas of retinal thickening and
hard exudates were estimated as continuous variables rather than on ordinal scales.13 FP and
OCT were evaluated independently of each other and independently of visits preceding or after
the visit being graded.
Creation of Photographic DME Severity Scale—In the ETDRS, poorer VA at baseline
and poorer visual outcomes were associated with larger area of retinal thickening within 1 disc
diameter of the center of the macula and with greater degree of thickening at the center assessed
photographically at study entry.3 ETDRS eyes were cross classified by the baseline values of
each of these measures, and mean baseline VA was calculated for each cell (see Appendix
online). Cells with similar VA were combined using cluster analysis and clinical judgment to
produce a nine-level DME severity scale (Gangnon R, et al. IOVS 2005;46:ARVO E-Abstract
3269). For use in this report, the scale was modified slightly. The scale and its modifications
and the reproducibility of the gradings are shown in the Appendix online (weighted κ for the
scale was 0.58).
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Correlations were calculated in repeated measures models (to account for the correlation
between eyes) based on the likelihood ratio as defined by Magee.14 Distributions of OCT
measures and VA were slightly skewed; however, truncating outliers at ±3 SD from the mean
gave similar results (data not shown). The simple κ statistic was used to describe the association
between two dichotomous variables. Statistical analyses were performed with commercial
software (SAS software ver. 9.1; SAS, Cary, NC).
Result
Correlations among OCT Measures at Baseline
Table 1 presents correlations among several OCT measures. Thickness at the center point and
mean thickness within the central subfield correlated highly (r = 0.99), reflecting the central
location of the center point within the relatively small area of the central subfield (<0.5 disc
area) and the tendency for retinal thickening to have a broad, gently sloping configuration. As
expected, correlations between the center point and surrounding areas of retina decreased as
area for comparison increased (r = 0.88 for mean inner zone thickness and r = 0.69 for retinal
volume). The central subfield thickness and maximum subfield thickening in the inner zone
(r = 0.97) and in the grid (r = 0.95) correlated highly, in part because the central subfield
provided the maximum value for the inner zone in 60% of eyes and for the grid in 50%.
Correlations between OCT and FP
Figure 2 presents the distribution of central subfield thickness measured with OCT at baseline
within each level of the modified ETDRS DME scale. The median (quartiles) for thickness
increased from 236 (214, 264) μm in level 1 of the photographic scale to 517 (455, 598) μm
in level 5C (r = 0.67). From level 2 upward, retinal thickness by OCT increased with each
increase on the scale, but interquartile ranges were broad and overlapped substantially and
there were many outliers.
Additional correlations between OCT and photographic measures are presented in Table 2.
The first three columns are limited to measures that provide comparisons between the two
methods at comparable locations: the entire grid (retinal volume versus area of thickened retina
in the grid, r = 0.74), the inner zone (mean inner zone thickness versus area of thickened retina
in the inner zone, r = 0.69), and at the center of the macula (center point thickness versus degree
of retinal thickening at the center of the macula, r = 0.61). For retinal volume, the 0.74
correlation with area of thickened retina in the grid by photographic grading appeared
somewhat better than the 0.59 correlation with the ETDRS DME severity scale, as would be
expected since retinal volume is based on the total area within the grid, whereas the DME
severity scale is restricted to the smaller inner zone. Correlations between the ETDRS DME
severity scale and the various OCT measures ranged from 0.59 for retinal volume to 0.71 for
maximum thickening in the grid. In the final column, which presents information for the 47
eyes in which both the OCT and the photographs were of good quality, correlations appeared
to be somewhat stronger. The small number of eyes in which both photographs and OCT were
graded as being of good quality was limited primarily by photographic quality (quality good,
fair, and borderline, respectively, in 15%, 63%, and 20% of photographs and in 65%, 20%,
and 15% of OCT scans).
No notable relationships were found with regard to correlations between the ETDRS DME
severity scale and any of the OCT retinal thickness measures examined within subgroups based
on area of hard exudate in fundus photographs, degree of retinal thickening, presence of cystoid
spaces in OCT scans, or VA (data not shown). Serous retinal detachment and vitreo-retinal
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surface abnormalities were too infrequent for meaningful analyses (7% and 3% of eyes,
respectively).
Detection of Retinal Thickening in Individual Subfields: OCT versus Photography
Agreement on presence of retinal thickening within individual subfields of the grid between
OCT and photography is shown in Table 3 (for OCT, retinal thickness ≥2 SD greater than
normal; for photographs ≥25% of the subfield thickened). With these definitions, the most
frequently involved subfield was the central subfield (64% by OCT and 57% by photography;
there was agreement in 73% of eyes, κ = 0.44). Involvement of the remaining subfields ranged
from 34% to 61% by OCT and from 16% to 55% by photography; agreement ranged from 66%
to 80% and κ = 0.31−0.58. Thickening was observed more often by OCT than by photography
in seven of the nine subfields. When the presence of retinal thickening detected by photography
was redefined as ≥5% of the subfield thickened, thickening was observed more often by
photography than by OCT in five of the nine subfields; however, the percent of agreement and
κ values were similar to those in Table 3 (data not shown).
OCT–FP Correlations at 12 Months and for Change between Baseline and 12 Months
Figure 3 presents information comparable to that in Figure 2 for 256 study eyes at the 12-month
visit. The correlation between central subfield thickness and the photographic DME scale
appeared somewhat weaker than that observed at baseline (r = 0.49 vs. .67). In addition, as
previously shown in Figure 2, interquartile ranges were broad and overlapped substantially,
and there were many outliers.
Change between baseline and 12 months as measured by OCT and estimated on the
photographic DME scale for these same eyes showed a correlation of similar strength to the
comparison at 12 months (r = 0.52; Fig. 4). Approximately 82% of the 45 eyes with
improvement by three or more levels on the photographic DME scale had a decrease of at least
40 μm in central subfield thickness by OCT (>38 μm half width of the 95% CI for replicate
measures of absolute change) but agreement between the two methods appeared to be less in
each of the other photographic change categories. Among the 76 eyes with no change on the
photographic scale, OCT demonstrated a decrease of 40 μm or more in 30 eyes and an increase
of this magnitude in six eyes.
Correlations with VA
Correlations of central subfield thickness and maximum inner zone thickening by OCT and of
the ETDRS DME severity scale with VA at the baseline and 12-month visits and with change
in VA between these visits are shown in Table 4. For both baseline and 12-month cohorts,
baseline correlations between VA and either OCT or FP were similar (0.47−0.59, first two
rows of the table). For OCT the correlations with VA at 12 months and with change in VA
between baseline and 12 months (0.48−0.55) were similar to those with VA at baseline, but
for the photographic scale, they appeared weaker (0.27 and 0.29). Corresponding correlations
for other OCT measures with VA (not shown in Table 4) were similar, except correlations were
weakest for retinal volume (r = 0.50 at baseline, 0.24 at 12 months, and 0.35 for change in VA
between these visits).
Discussion
The correlations between the OCT measures of retinal thickness and the photographic DME
severity scale analyzed in this report (r = 0.59−0.71, Table 2) may be characterized as moderate
at best. Several factors may contribute to this result. First, in all parts of the grid except at its
center point, OCT and photography assess different dimensions of retinal thickening: mean
thickness by OCT, and area of thickened retina by photography. Although greater degrees of
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retinal thickening are usually accompanied by greater areas of thickened retina, this is not
necessarily the case. Furthermore, within any given area of retinal thickening, except at the
center of the macula, the photographic grading does not distinguish between degrees of
thickening. Second, photographic estimates of retinal thickening are highly dependent on good
quality stereoscopic photographs. Correlations increased from the range of 0.59 to 0.71 when
analyzing all the eyes in the cohort to the range of 0.71 to 0.82 when the analysis was limited
to those eyes in which both the OCT and the photographs were graded as being of good quality.
Finally, estimation of retinal thickness, even in good-quality photographs, depends on detection
of the inner surface of the retina, which may be invisible in and near the foveal avascular zone
if normal retinal transparency is maintained and hard exudates are absent.
Agreement between OCT and photography on presence or absence of retinal thickening within
each subfield of the grid (Table 3) was fair to moderate, according to the guidelines suggested
by Landis and Koch.15 Several factors may contribute to this result: The subfields of the OCT
and photographic grids do not match exactly (Fig. 1); the density of OCT A-scans in the outer
subfields is low, with 1-clock-hour wide spaces between each of the six scan lines (B-scans);
the cut points for presence or absence differ, in that for OCT all A-scans in each subfield are
averaged, decreasing the contribution of small focal areas of thickening, whereas in
photographs such areas have full weight (and often are easily recognized). Scanning patterns
that provide a greater density of A-scans in the outer subfields and algorithms that average
them over smaller areas could be used to overcome some of these problems.16
Comparison of OCT and photography in assessing change between baseline and follow-up
suggested that change in retinal thickness measured by OCT may be a more sensitive measure
than change on the ETDRS DME scale (Fig. 4). Given the limited reliability of change by only
one step on the photographic scale (see Appendix online), it seems appropriate to pool the no-
change, one-level–improved and one-level–worsened categories in Figure 4 as no definite
change. If this concept had been applied, 134 eyes would have been considered stable by the
photographic measure; however, 53 (40%) of these eyes had a decrease in retinal thickening
of ≥40 μm by OCT assessment, an amount sufficient to make measurement error an unlikely
explanation.
The correlations of OCT measurements of central subfield thickness and maximum thickening
in the inner zone with concurrent VA were only modest (r = 0.53−0.59, Table 4) and similar
to those reported previously for OCT center point and visual acuity.17 Correlation between
photographic gradings and VA were similar (r = 0.47−0.50) at baseline to those between OCT
measurements and VA, but tended to be lower at 1 year (r = 0.29) than that between OCT and
VA.
Overall, these analyses support the use of OCT as the principal method for documenting retinal
thickness and particularly for observing change in retinal thickness in eyes with DME in clinical
trials. OCT provides quantitative estimates of change that appear to be more sensitive and more
reproducible than change on the ordinal ETDRS DME severity scale. OCT also has practical
advantages. Acquisition of good-quality OCT scans is generally easier for the OCT operator
to accomplish, easier for the patient to undergo given the more limited light exposure, and less
time consuming for both patient and operator. In addition, the scan quality is less likely to be
compromised by mild lens opacities or limited pupillary dilation.
Our study is limited by exclusion of assessment of OCT and FP information on most aspects
of DME other than retinal thickness. It is well known, however, from clinical experience that
time domain OCT is less suitable than fundus photography for documenting location and
severity of other morphologic features of DME, such as hard exudates, retinal hemorrhages,
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microaneurysms, and vascular abnormalities. Furthermore, OCT cannot provide information
on overall retinopathy severity, for which FP remains the gold standard.
In summary, in our analyses there was a moderate correlation between OCT measurements of
retinal thickness and a DME severity scale based on gradings of retinal thickening in
stereoscopic fundus photographs and between these measures and VA. OCT provides a more
sensitive and reproducible measure of retinal thickening but is less suitable for documenting
other morphologic features of diabetic retinopathy and DME than is FP. However, changes in
these measures do not necessarily reflect changes in VA, particularly for a specific individual.
The decision to use either, both, or neither of these modalities in a particular clinical research
study depends largely on the focus of the study and the primary study question.
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Comparison of ETDRS (black) and OCT (white) macular grids. When centered on the macula,
the solid circles and radial lines divide the area within the grid into nine subdivisions
(subfields): one central, four inner, and four outer. The central and four inner subfields
combined comprise the inner zone. The diameter of the ETDRS grid is four standard disc
diameters, and its area is 16 disc areas. In the ETDRS, the historical precedent for considering
the diameter of the average normal disc to be 1500 μm was adopted, resulting in designations
of 6000, 3000, and 1000 μm for the diameters of the three solid circles. With the advent of
photodynamic therapy and digital fundus photography, 1800 μm has been adopted as a more
realistic estimate of the diameter of the average normal disc. With this convention, the
diameters of the ETDRS grid may be expressed as 7200, 3600, and 1200 μm, whereas those
of the OCT grid remain 6000, 3000, and 1500 μm.
Davis et al. Page 10














Distribution of retinal thickness in the central subfield by ETDRS DME severity level at
baseline. The boxes indicate 25th to 75th percentiles and the whiskers the 10th and 90th
percentiles. Solid line: median; dashed line: mean.
Davis et al. Page 11














Distribution of retinal thickness in the central subfield by ETDRS DME severity level at 12
months. The plots are as described in Figure 2.
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Distribution of baseline to 12-month change in retinal thickness in the central subfield by
change in ETDRS DME severity level. Negative change in OCT values indicates decrease in
thickening.
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Table 4





Visual Acuity n Central Subfield
Thickness (r)
Maximum Thickening
in the Inner Zone† (r)
Baseline (primary cohort) 411 0.47 0.57 0.59
Baseline (follow-up cohort) 223 0.50 0.54 0.57
12 Months 223 0.29 0.53 0.55
Change from baseline to 12 months 223 0.27 0.48 0.50
*
Excludes eyes with abnormality other than DME on clinical examination, reducing acuity by three lines according to the investigator's opinion, and eyes
with moderate or worse lens opacity with acuity worse than 20/32: 24 eyes at baseline and 33 eyes at 12 months.
†
Defined as observed thickness minus the mean normal thickness.
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